These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 1320011)
21. Identification of a novel thrombin receptor sequence required for activation-dependent responses. Bahou WF; Kutok JL; Wong A; Potter CL; Coller BS Blood; 1994 Dec; 84(12):4195-202. PubMed ID: 7994033 [TBL] [Abstract][Full Text] [Related]
22. The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase. Hung DT; Wong YH; Vu TK; Coughlin SR J Biol Chem; 1992 Oct; 267(29):20831-4. PubMed ID: 1328213 [TBL] [Abstract][Full Text] [Related]
23. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Mathews II; Padmanabhan KP; Ganesh V; Tulinsky A; Ishii M; Chen J; Turck CW; Coughlin SR; Fenton JW Biochemistry; 1994 Mar; 33(11):3266-79. PubMed ID: 8136362 [TBL] [Abstract][Full Text] [Related]
24. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor. Chao BH; Kalkunte S; Maraganore JM; Stone SR Biochemistry; 1992 Jul; 31(27):6175-8. PubMed ID: 1320929 [TBL] [Abstract][Full Text] [Related]
25. Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand. Moschonas IC; Kellici TF; Mavromoustakos T; Stathopoulos P; Tsikaris V; Magafa V; Tzakos AG; Tselepis AD Platelets; 2017 Dec; 28(8):812-821. PubMed ID: 28267389 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms of thrombin receptor agonist specificity. Chimeric receptors and complementary mutations identify an agonist recognition site. Nanevicz T; Ishii M; Wang L; Chen M; Chen J; Turck CW; Cohen FE; Coughlin SR J Biol Chem; 1995 Sep; 270(37):21619-25. PubMed ID: 7665575 [TBL] [Abstract][Full Text] [Related]
28. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351 [TBL] [Abstract][Full Text] [Related]
29. Structure-activity studies of the thrombin receptor activating peptide. Sabo T; Gurwitz D; Motola L; Brodt P; Barak R; Elhanaty E Biochem Biophys Res Commun; 1992 Oct; 188(2):604-10. PubMed ID: 1332704 [TBL] [Abstract][Full Text] [Related]
30. Enhancement of thrombin receptor activation by thrombin receptor-derived heptapeptide with para-fluorophenylalanine in place of phenylalanine. Nose T; Shimohigashi Y; Ohno M; Costa T; Shimizu N; Ogino Y Biochem Biophys Res Commun; 1993 Jun; 193(2):694-9. PubMed ID: 8390250 [TBL] [Abstract][Full Text] [Related]
31. Homologous desensitization of HEL cell thrombin receptors. Distinguishable roles for proteolysis and phosphorylation. Brass LF J Biol Chem; 1992 Mar; 267(9):6044-50. PubMed ID: 1313426 [TBL] [Abstract][Full Text] [Related]
32. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function. Faruqi TR; Weiss EJ; Shapiro MJ; Huang W; Coughlin SR J Biol Chem; 2000 Jun; 275(26):19728-34. PubMed ID: 10779527 [TBL] [Abstract][Full Text] [Related]
33. [Cellular receptor of thrombin]. Lasne D; Rendu F; Aiach M Ann Biol Clin (Paris); 1994; 52(4):257-60. PubMed ID: 7802348 [TBL] [Abstract][Full Text] [Related]
36. Shutoff and agonist-triggered internalization of protease-activated receptor 1 can be separated by mutation of putative phosphorylation sites in the cytoplasmic tail. Hammes SR; Shapiro MJ; Coughlin SR Biochemistry; 1999 Jul; 38(29):9308-16. PubMed ID: 10413505 [TBL] [Abstract][Full Text] [Related]
37. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes. Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist. Seiler SM; Peluso M; Michel IM; Goldenberg H; Fenton JW; Riexinger D; Natarajan S Biochem Pharmacol; 1995 Feb; 49(4):519-28. PubMed ID: 7872957 [TBL] [Abstract][Full Text] [Related]
39. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. Molino M; Blanchard N; Belmonte E; Tarver AP; Abrams C; Hoxie JA; Cerletti C; Brass LF J Biol Chem; 1995 May; 270(19):11168-75. PubMed ID: 7744748 [TBL] [Abstract][Full Text] [Related]
40. "Thrombin" receptor-directed ligand accounts for activation by thrombin of platelet phospholipase C and accumulation of 3-phosphorylated phosphoinositides. Huang RS; Sorisky A; Church WR; Simons ER; Rittenhouse SE J Biol Chem; 1991 Oct; 266(28):18435-8. PubMed ID: 1655750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]